Literature DB >> 8528742

FMS hemizygosity in myeloid dysplasia and acute myeloid leukemia with chromosomal aberration del(5)(q) demonstrated by polymerase chain reaction.

M Pfeilstöcker1, R Grill, E Koller, O Krieger, E Pittermann, H Karlic.   

Abstract

Interstitial deletions of the long arm of chromosome 5 del(5)(q), are recurring aberrations in the myelodysplastic syndrome and acute myeloid leukemia. Several genes located in region (5)(q23-34) have been implicated as being of pathogenic importance. In this study seven samples of six patients with myelodysplastic syndrome and acute myeloid leukemia who have the del(5)(q) aberration were analyzed by polymerase chain reaction (PCR) and Southern blot technique. FMS hemizygosity was demonstrated in all patients. PCR analysis from peripheral blood samples confirmed the observations of this aberration found by semiquantitative Southern blot. PCR-based analysis can be used for primary diagnosis in addition to cytogenetic evaluation and for follow-up in patients with del(5)(q) aberration.

Entities:  

Mesh:

Year:  1995        PMID: 8528742     DOI: 10.1007/bf00240139

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  24 in total

1.  A physical and genetic linkage map of the distal long arm of human chromosome 5.

Authors:  M Thangavelu; W L Neuman; R Espinosa; Y Nakamura; C A Westbrook; M M Le Beau
Journal:  Cytogenet Cell Genet       Date:  1992

2.  [The cytogenetics of acute leukemia].

Authors:  H Nowotny; M Lambrou; L Sreter; D Lutz
Journal:  Folia Haematol Int Mag Klin Morphol Blutforsch       Date:  1988

Review 3.  The 5q- abnormality.

Authors:  S D Nimer; D W Golde
Journal:  Blood       Date:  1987-12       Impact factor: 22.113

4.  Molecular anatomy of a 5q interstitial deletion.

Authors:  L Nagarajan; B Lange; L Cannizzaro; J Finan; P C Nowell; K Huebner
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

5.  Expression of the human c-fms proto-oncogene in hematopoietic cells and its deletion in the 5q- syndrome.

Authors:  A W Nienhuis; H F Bunn; P H Turner; T V Gopal; W G Nash; S J O'Brien; C J Sherr
Journal:  Cell       Date:  1985-09       Impact factor: 41.582

6.  Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia.

Authors:  K Tobal; A Pagliuca; B Bhatt; N Bailey; D M Layton; G J Mufti
Journal:  Leukemia       Date:  1990-07       Impact factor: 11.528

Review 7.  The 5q-anomaly.

Authors:  H Van den Berghe; K Vermaelen; C Mecucci; D Barbieri; G Tricot
Journal:  Cancer Genet Cytogenet       Date:  1985-07

8.  Chromosome aberrations in CD34-positive acute myeloid leukemia. Correlation with clinicopathologic features.

Authors:  F Fagioli; A Cuneo; M G Carli; A Bardi; N Piva; R Previati; G M Rigolin; L Ferrari; R Spanedda; G Castoldi
Journal:  Cancer Genet Cytogenet       Date:  1993-12

9.  Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosome.

Authors:  L Nagarajan; J Zavadil; D Claxton; X Lu; J Fairman; J A Warrington; J J Wasmuth; A C Chinault; C E Sever; M L Slovak
Journal:  Blood       Date:  1994-01-01       Impact factor: 22.113

10.  Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders.

Authors:  W L Neuman; C M Rubin; R B Rios; R A Larson; M M Le Beau; J D Rowley; J W Vardiman; J L Schwartz; R A Farber
Journal:  Blood       Date:  1992-03-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.